These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19589292)

  • 61. Psoriasis options abound. Ongoing research on Enbrel and Raptiva supports their use in psoriasis treatment.
    Krueger GG
    Health News; 2004 Jan; 10(1):10-1. PubMed ID: 15002383
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment of moderate to severe plaque psoriasis with concomitant efalizumab and narrow-band ultraviolet B phototherapy.
    Kircik LH; Liu C; Goffe BS
    J Drugs Dermatol; 2008 Oct; 7(10):947-52. PubMed ID: 19112758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized trial of etanercept as monotherapy for psoriasis.
    Gottlieb AB; Matheson RT; Lowe N; Krueger GG; Kang S; Goffe BS; Gaspari AA; Ling M; Weinstein GD; Nayak A; Gordon KB; Zitnik R
    Arch Dermatol; 2003 Dec; 139(12):1627-32; discussion 1632. PubMed ID: 14676082
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M; Mazzotta A; de Felice C; Papoutsaki M; Chimenti S
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study.
    Demirsoy EO; Kıran R; Salman S; Cağlayan C; Aktürk AS; Bayramgurler D; Bilen N
    J Drugs Dermatol; 2013 Sep; 12(9):1039-43. PubMed ID: 24002153
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Our experience with etanercept in the treatment of psoriasis.
    Kokelj F; Miertusova Tothova S; Patamia M; Trevisan G
    Acta Dermatovenerol Croat; 2006; 14(4):241-5. PubMed ID: 17311738
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recalcitrant palmoplantar pustular psoriasis treated with etanercept.
    Floristan U; Feltes R; Ramírez P; Alonso ML; De Lucas R
    Pediatr Dermatol; 2011; 28(3):349-50. PubMed ID: 21371112
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis.
    Moore A; Gordon KB; Kang S; Gottlieb A; Freundlich B; Xia HA; Stevens SR
    J Am Acad Dermatol; 2007 Apr; 56(4):598-603. PubMed ID: 17113190
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of etanercept treatment on lipid profile in patients with moderate-to-severe chronic plaque psoriasis: a retrospective cohort study.
    Lestre S; Diamantino F; Veloso L; Fidalgo A; Ferreira A
    Eur J Dermatol; 2011; 21(6):916-20. PubMed ID: 21983007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient-reported outcomes and health-care resource utilization in patients with psoriasis treated with etanercept: continuous versus interrupted treatment.
    Gelfand JM; Kimball AB; Mostow EN; Chiou CF; Patel V; Xia HA; Freundlich B; Stevens SR
    Value Health; 2008; 11(3):400-7. PubMed ID: 18489665
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of Biofeedback and Cognitive-behavioural Therapy in Psoriatic PatientsA Single-blind, Randomized and Controlled Study with Added Narrow-band Ultraviolet B Therapy.
    Piaserico S; Marinello E; Dessi A; Linder MD; Coccarielli D; Peserico A
    Acta Derm Venereol; 2016 Aug; 96(217):91-5. PubMed ID: 27283367
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Impact of SPA therapy with sulphureous mineral water on quality of life and psychological distress in chronic plaque psoriasis].
    Costantino M; Filippelli A
    Clin Ter; 2014; 165(4):e277-84. PubMed ID: 25203343
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II).
    Carrascosa JM; Galán M; de Lucas R; Pérez-Ferriols A; Ribera M; Yanguas I
    Actas Dermosifiliogr; 2016 Nov; 107(9):712-729. PubMed ID: 27344068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational study.
    Fink C; Schank TE; Trenkler N; Uhlmann L; Schäkel K
    BMJ Open; 2017 Jun; 7(6):e014279. PubMed ID: 28667200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Managing moderate-to-severe psoriasis in the elderly.
    Balato N; Patruno C; Napolitano M; Patrì A; Ayala F; Scarpa R
    Drugs Aging; 2014 Apr; 31(4):233-8. PubMed ID: 24554398
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Itch in Psoriasis Management.
    Szepietowski JC; Reich A
    Curr Probl Dermatol; 2016; 50():102-10. PubMed ID: 27578078
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Psychosocial factors in psoriasis. A pilot study].
    Bahmer JA; Petermann F; Kuhl J
    Hautarzt; 2007 Nov; 58(11):959-65. PubMed ID: 17701145
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Psoriasis and stress: a prospective study.
    Gaston L; Lassonde M; Bernier-Buzzanga J; Hodgins S; Crombez JC
    J Am Acad Dermatol; 1987 Jul; 17(1):82-6. PubMed ID: 3611457
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy.
    Fortune DG; Richards HL; Kirby B; Bowcock S; Main CJ; Griffiths CE
    Br J Dermatol; 2002 Mar; 146(3):458-65. PubMed ID: 11952546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An overview and update of psoriasis.
    Green L
    Nurs Stand; 2011 May 4-10; 25(35):47-55; quiz 56. PubMed ID: 21667856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.